scholarly article | Q13442814 |
P356 | DOI | 10.1097/MPA.0B013E31825ABF8C |
P698 | PubMed publication ID | 22850624 |
P2093 | author name string | Valery E P P Lemmens | |
Simon W Nienhuijs | |||
Misha D Luyer | |||
Ignace H J T de Hingh | |||
Irene Thomassen | |||
Yvonne L Klaver | |||
P433 | issue | 1 | |
P921 | main subject | peritoneal carcinomatosis | Q2071182 |
P304 | page(s) | 72-75 | |
P577 | publication date | 2013-01-01 | |
P1433 | published in | Pancreas | Q15762014 |
P1476 | title | Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study | |
P478 | volume | 42 |
Q92140598 | Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review |
Q88735258 | Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway |
Q90346763 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a patient with peritoneal carcinomatosis from a pancreatic cystadenocarcinoma: A case report |
Q64108949 | Development and Biological Analysis of a Novel Orthotopic Peritoneal Dissemination Mouse Model Generated Using a Pancreatic Ductal Adenocarcinoma Cell Line |
Q64063210 | Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC) |
Q37013343 | Evaluation of expansile nanoparticle tumor localization and efficacy in a cancer stem cell-derived model of pancreatic peritoneal carcinomatosis |
Q90244152 | FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective study |
Q47111181 | Highly Specific and Sensitive Fluorescent Nanoprobes for Image-Guided Resection of Sub-Millimeter Peritoneal Tumors |
Q89471694 | Influence of peritoneal carcinomatosis on perioperative outcome in palliative gastric bypass for malignant gastric outlet obstruction - a retrospective cohort study |
Q40638288 | Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites |
Q47809171 | Long-term survival with peritoneal mucinous carcinomatosis from intraductal mucinous papillary pancreatic carcinoma treated with complete cytoreduction and hyperthermic intraperitoneal chemotherapy. |
Q55220021 | Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids. |
Q92617979 | Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) |
Q39171689 | Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications. |
Q39442876 | Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer |
Q90568096 | Percutaneous Computed Tomography-Guided Coaxial Core Biopsy for the Diagnosis of Pancreatic Tumors |
Q38958621 | Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis. |
Q43880060 | Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors |
Q38779523 | Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). |
Q44424534 | Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma |
Q35057350 | Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer |
Q37716482 | Prognostic significance of positive peritoneal cytology in resectable pancreatic cancer: a systemic review and meta-analysis |
Q45228180 | Reappraisal of peritoneal washing cytology in 984 patients with pancreatic ductal adenocarcinoma who underwent margin-negative resection |
Q40506490 | Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma |
Q50795446 | Survival benefit of intravenous and intraperitoneal paclitaxel with S-1 in pancreatic ductal adenocarcinoma patients with peritoneal metastasis: a retrospective study in a single institution. |
Q88709397 | The investigation of the survival time after recurrence in patients with pancreatic ductal adenocarcinoma for individualization of adjuvant chemotherapy |
Search more.